The Penicillins and Streptomycins dosage market in Spain has consistently declined in market size value from 2013 to 2023, starting at $309.25 million and reaching $197.59 million by 2023. Over the past decade, the annual decline continues with the market shrinking by an average annual rate of around 2.19% over the last five years. The past two years alone saw year-on-year decreases of 2.09% and 1.96% respectively.
Future trends to watch for include:
- Potential market stabilization or further decline depending on antibiotic use policies.
- Innovations in alternative antibiotic therapies potentially impacting market dynamics.
- Stricter regulations or increased generics competition possibly affecting market pricing and revenues.
How does Spain rank in Penicillins and Streptomycins in Dosage Market Size Value?
| # | 33 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 4,303,400,000 | 2023 | +0.61% | +1.48% | View data |
| 2 | 2 United Kingdom | 730,000,000 | 2023 | -1.31% | -1.45% | View data |
| 3 | 3 France | 717,200,000 | 2023 | -1.91% | +0.034% | View data |
| 4 | 4 Italy | 622,330,000 | 2023 | -3.96% | -4.86% | View data |
| 5 | 5 Germany | 476,270,000 | 2023 | +1.03% | +1.1% | View data |
| 8 | 8 Vietnam | 256,220,000 | 2023 | +4.62% | +6.03% | View data |
| 9 | 9 Canada | 209,600,000 | 2023 | -2.3% | +1.59% | View data |
| 10 | 10 Spain | 197,590,000 | 2023 | -1.96% | -2.19% | |
| 11 | 11 Poland | 143,340,000 | 2023 | -0.61% | -1.38% | View data |
| 12 | 12 South Africa | 142,320,000 | 2023 | -0.66% | -0.0042% | View data |
